UPDATE : Thursday, May 23, 2019
상단여백
Sillajen, CHA Hospital to co-develop immunotherapy
Sillajen said Wednesday it has entered an agreement with CHA Bundang Hospit...
by Lee Han-soo  |  2019-05-22 18:26
라인
SK Bioscience's shingles vaccine increases market share
Skyzoster, the first shingles vaccine domestically developed by SK Bioscien...
by Lee Han-soo  |  2019-05-22 17:04
라인
NHIS prepares mandatory health insurance enrollment for expats
The National Health Insurance Service (NHIS) said it would run more foreign...
by Song Soo-youn  |  2019-05-22 15:49
라인
Handok, Sanofi to promote vaccines jointly
Handok said Wednesday that it has agreed with Sanofi Pasteur to co-promote ...
by Lee Han-soo  |  2019-05-22 15:48
라인
CMC researchers discover new strategy in treating liver cancer
A Catholic Medical Center (CMC) research team has found that by controlling...
by Lee Han-soo  |  2019-05-21 17:13
라인
Legislator, activists call for revoking Invossa license, conducting probes
A lawmaker and civic groups urged the government to nullify the license of ...
by Jeong Sae-im  |  2019-05-21 16:03
라인
Ministry grants additional indication to MSD’s immunotherapeutic drug
Keytruda, immunotherapy from MSD, has obtained additional approval from the...
by Lee Han-soo  |  2019-05-21 14:55
라인
Japan issued safety warning on Lilly’s breast cancer drug. Will Korea, too?
Japan’s Health Ministry warned that Eli Lilly’s breast cancer therapy Verze...
by Kim Yun-mi  |  2019-05-21 14:19
라인
[Pre-ASCO 2019] ABL Bio: ABL001- bispecific antibody with indications for anti-cancer therapy
ABL Bio is set to become the first Korean company to present its poster ses...
by Lee Han-soo  |  2019-05-21 12:47
라인
Researchers identify novel protein enzymes that repair mutant DNA
Korean researchers have identified the function of a novel protein enzyme c...
by Lee Han-soo  |  2019-05-21 12:00
라인
[Reporter’s Notebook] ‘Wanna know what’s going on with MSD Korea?’
“Is there any trouble between Korea Biomedical Review and MSD Korea?”People...
by Jeong Sae-im  |  2019-05-21 11:44
라인
Roche’s breast cancer drug gains more insurance benefits
The Ministry of Health and Welfare has granted additional reimbursement to ...
by Lee Han-soo  |  2019-05-21 10:44
라인
Low-income, single women more vulnerable to osteoporosis
Women who are living by herself, earning low incomes, and having poor knowl...
by Kim Yun-mi  |  2019-05-20 15:40
라인
Bridge Biotherapeutics releases first-in-human study for idiopathic pulmonary fibrosis treatment
Bridge Biotherapeutics announced that the company has presented interim dat...
by Lee Han-soo  |  2019-05-20 15:29
라인
Hospital beds going up in Korea contrary to OECD's trend
As people have other tools to receive medical service outside hospitals, mo...
by Song Soo-youn  |  2019-05-20 15:19
라인
Regulator inspecting Kolon TissuGene in US this week
A delegation of the Ministry of Food and Drug Safety left for the U.S. on S...
by Lee Hye-seon  |  2019-05-20 14:22
라인
'Yuyu should – and will -- be reborn as new drug developer'
Older Koreans are familiar with Yuyu Pharma and its flagship vitamin supple...
by Lee Han-soo  |  2019-05-17 17:11
라인
[Pre-ASCO 2019] Samsung Bioepis: Ontruzant - HER2-positive breast cancer treatment
Samsung Bioepis will continue to present its biosimilar pipeline at ASCO th...
by Lee Han-soo  |  2019-05-17 16:19
라인
[Special] Is Watson hype cooling down?
IBM’s Watson for Oncology, an artificial intelligence-led diagnosis program...
by Kim Eun-young  |  2019-05-17 15:40
라인
Kolon to follow 3,700 Invossa-treated patients for 15 years
Kolon Life Science said it would conduct a long-term follow-up study on ove...
by Jeong Sae-im  |  2019-05-17 15:38
여백
여백
여백
Back to Top